ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors.

Atish D Choudhury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.